
A New Middle Eastern War Ignites, Markets Swing On Early Bets That Trump Will Chicken Out Again
With the Israel-Iran conflict, we are not talking merely about shipping products around the world: we are talking about people's very lives.
With the Israel-Iran conflict, we are not talking merely about shipping products around the world: we are talking about people's very lives.
It's not just about having money – it's about keeping more of it.
Acquiring FarmboxRx will help Pyx Health tackle food insecurity, a challenge many of its members struggle with.
From AI to value-based care, three VCs shared their controversial takes on healthcare during a recent panel discussion at the MedCity INVEST conference.
To survive over the next three years, this has to be about raw, unadulterated national self-interest.
Explore 5 expert-backed reasons law firms are rethinking the billable hour and how legal billing software is leading the way.
Do you have enough saved to maintain your lifestyle without a regular paycheck?
Whatever Trump says, I can guarantee that we're not going to both raise a ton of tax revenue from tariffs and only have them on for a short time.
UnitedHealth Group announced that Andrew Witty will step down as CEO due to ‘personal reasons.’ He is being replaced by Stephen J. Hemsley, who served as the company’s CEO from 2006 to 2017.
Truly, the saddest words of heart or pen ...
Join the webinar on September 25th and learn some quick wins you can implement right away.
If you're very rich, cheating on your taxes will be easier to get away with. That's something. If you're very rich.
There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and the resulting economic uncertainty. Hospitals are putting off mergers for the time being, though some are forming joint ventures as a defense mechanism against financial uncertainty. Many are instead shedding assets to cope with the current macroeconomic environment.
With comprehensive planning, retirement becomes not an ending but a transition to a rewarding new phase of life.
Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene therapy and cardiometabolic disease. The plans follow U.S. capital expenditure announcements from several big pharmaceutical companies.